In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo

Eric R Bates

doi:10.7326/J24-0026

In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo

Ann Intern Med. 2024 May;177(5):JC54. doi: 10.7326/J24-0026. Epub 2024 May 7.

Author

Eric R Bates¹

Affiliation

¹ University of Michigan, Ann Arbor, Michigan, USA (E.R.B.).

PMID: 38710085
DOI: 10.7326/J24-0026

Abstract

Roubille F, Bouabdallaoui N, Kouz S, et al. Low-dose colchicine in patients with type 2 diabetes and recent myocardial infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. 2024;47:467-470. 38181203.

Publication types

Randomized Controlled Trial

MeSH terms

Aged
Colchicine* / administration & dosage
Colchicine* / therapeutic use
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Female
Humans
Male
Middle Aged
Myocardial Infarction* / prevention & control